CMS Finalizes 2.48% Increase in Medicare Advantage Payment Rates for 2027

This adjustment signals a stronger financial outlook for Medicare Advantage plans, impacting healthcare access and insurance costs.

• On April 6, 2026, CMS finalized a 2.48% net average increase in payment rates for Medicare Advantage plans for 2027.
• This increase is significantly higher than the 0.09% proposed earlier in January 2026, reflecting a robust growth rate.
• Health insurer stocks surged in premarket trading, with major players like Humana and UnitedHealth seeing gains of 3-11%.

• Medicare Advantage plans are private alternatives to traditional Medicare, with payments based on demographic risk and quality metrics.
• The January 2026 proposal raised concerns over margin compression due to scrutiny of upcoding practices and fiscal sustainability.
• Finalization of rates incorporated updated data and adjustments to enhance payment accuracy, addressing previous actuarial discrepancies.

The recent decision by the Centers for Medicare & Medicaid Services (CMS) to finalize a 2.48% net increase in Medicare Advantage payment rates for 2027 is a pivotal moment for the healthcare insurance sector. This adjustment, which translates to over $13 billion in additional payments, is driven by a combination of factors including an effective growth rate of 5.33%, offset by rebasing, risk model revisions, and coding exclusions.

The initial proposal in January 2026 suggested a mere 0.09% increase, which raised alarms among insurers regarding potential margin compression and the sustainability of their business models. The healthcare industry was apprehensive about the implications of such a low increase, particularly in light of ongoing scrutiny over upcoding practices—where insurers may overstate patient diagnoses to receive higher payments.

By revising the payment rates upward, CMS not only alleviates some of these concerns but also reinforces the viability of Medicare Advantage plans as a competitive alternative to traditional Medicare. The updated payment structure retains the 2024 risk adjustment model, which is crucial for minimizing volatility in payments. Additionally, the exclusion of unlinked chart review diagnoses aims to enhance payment accuracy, ensuring that insurers are compensated fairly based on the actual health status of their enrollees.

This decision has immediate implications for health insurers, as evidenced by the stock market response. Major health insurance stocks, including Humana and UnitedHealth, experienced significant premarket trading gains, reflecting investor optimism about the enhanced revenue potential stemming from the increased payment rates. Analysts have characterized the revision as exceeding expectations, with various firms projecting that it will enable margin expansion and enhance the investability of these stocks.

In the broader context, this increase not only impacts the financial health of insurers but also has potential downstream effects on healthcare access and costs for beneficiaries. As insurers receive more funding, they may be incentivized to improve services and expand coverage options, which could ultimately benefit Medicare recipients. However, the sustainability of these increases will depend on ongoing regulatory oversight and the ability of insurers to manage costs effectively.

• Health insurers: Major companies like Humana and UnitedHealth will see immediate financial benefits, influencing their stock performance.
• Investors: Those holding shares in health insurance stocks will likely experience increased portfolio values.
• Medicare beneficiaries: Potential improvements in services and coverage options may arise from the increased funding for Medicare Advantage plans.

• Stock performance of health insurers: Monitor how shares of companies like Humana and UnitedHealth respond in the coming weeks. This will indicate market confidence in the sustainability of the new payment rates.
• CMS regulatory actions: Watch for any future announcements from CMS regarding adjustments to payment models or oversight measures that could impact the Medicare Advantage landscape.
• Beneficiary feedback: Keep an eye on surveys and reports from Medicare beneficiaries regarding their experiences with coverage and services, as these will reflect the real-world impact of the payment increase.